Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors

Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors

US Patent 9873740 · Granted Jan 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2025
Diagnostic and therapeutic methods for the treatment of rheumatoid arthritis (RA2025
HER-2 targeted bispecific compositions and methods for making and using the same2025
Antibodies binding to VISTA at acidic pH2025
Antibodies binding to vista at acidic pH2024
Antibodies binding to vista at acidic pH2024
Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the tre2024
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2024
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and 2023
Anti-interleukin-33 antibodies and uses thereof2023
Anti-CD8 antibodies and uses thereof2023
Antibodies binding to VISTA at acidic pH2023